About Aleksandar Videnovic, MD

Aleksandar Videnovic, MD, MSc is an Associate Professor of Neurology at Harvard Medical School, Director of the Division of  Sleep Medicine at MGH, and Director of the MGH Program on Sleep, Circadian Biology and Neurodegeneration. He completed Neurology residency at Northwestern University Feinberg School of Medicine in Chicago, followed by fellowships in Movement Disorders at Rush University and Sleep Medicine at Northwestern University. Dr. Videnovic holds a Master of Science degree in clinical research. His clinical activities include the diagnosis and treatment of a wide spectrum of movement disorders and co-existent sleep dysfunction associated with these disorders. Dr. Videnovic directs a clinical and research program on REM Sleep Behavior Disorder at MGH. His research programs are focused on the interface of sleep, circadian biology and neurodegeneration, as well as on clinical trials in sleep and neurodegenerative disorders, with an emphasis on Parkinson's disease. Dr. Videnovic serves on numerous scientific committees within professional organizations, including the American Academy of Neurology, the American Academy of Sleep Medicine, the International RBD Study Group and the Parkinson Study Group. 

Departments, Centers, & Programs:

Clinical Interests:




Mass General Neurology
55 Fruit St.
Boston, MA 02114
Phone: 855-644-6387

Medical Education

  • MD, University of Belgrade School of Medicine
  • Residency, Northwestern Memorial Hospital
  • Residency, University of Belgrade School of Medicine
  • Fellowship, Rush University Medical Center

American Board Certifications

  • Neurology, American Board of Psychiatry and Neurology
  • Sleep Medicine, American Board of Internal Medicine

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Dr. Videnovic's research is focused on clinical investigations in sleep and movement disorders. Specifically, his group has positioned sleep and circadian rhythms as novel therapeutic targets for neurodegenerative disorders. Another major research interest is REM Sleep Behavior Disorder, a parasomnia that represents a prodromal stage of synuclein-specific neurodegenerative disorders, such as Parkinson's disease and Dementia with Lewy Bodies.  This line of research aims to detect biomarkers of neurodegeneration within the RBD phenotype that will inform planing of future disease modifying trials for these neurodegenerative disorders. Dr. Videnovic is involved in wide range of clinical trials in movement disorders. His research has been supported by NIH/NINDS, Michael J Fox Foundation for Parkinson's Research, National Parkinson Foundation, American Brain Foundation and Parkinson's Disease Foundation.


Reviews: Comments and Ratings